The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Johnson & Johnson (NYSE:JNJ) was among the stocks Jim Cramer discussed on Mad Money, along with the recent sell-off in the market. Cramer was bullish on the stock during the episode, as he said:

Now, you can make good money for a while if you go all in on what’s hot, but I never do it because I know it’ll eventually blow up in your face… That’s why we run a diversified fund for the Investing Club. When you’re diversified, at any given moment, you’re going to own some losers, though, or at least some stocks that aren’t working. These stocks will lag while the data center roars, but they preserve your sanity when you get a tsunami-like sell-off in the hottest stocks out there.

Well, the tsunami of data center selling is here, and today’s the day when I’m kind of patting myself on the back for keeping the Charitable Trust diversified, not going all in on the data center complex. Today’s the day when we’re grateful for our Johnson & Johnson position. Great new drug profits. Triple-A balance sheet, better than the United States… See, the lesson’s clear, people. The P&Gs and the J&Js in your portfolio allow you to safely own the techs. They’re kind of like permits. But if you don’t take something off the table of the techs when you’re up big, I think you’re going to live to regret it.

Photo by Nicholas Cappello on Unsplash

Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and medical technologies, with treatments in immunology, oncology, neuroscience, cardiovascular care, and infectious diseases.

While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.